Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2011, Article ID 269515, 4 pages
http://dx.doi.org/10.1155/2011/269515
Clinical Study

Comparison of Oral Zinc Sulfate with Systemic Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

1Research Center for Skin Disease and Cutaneous Leishmaniasis, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran
2Department of Social Medicine, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran
3Mashhad University of Medical Sciences (MUMS), Mashhad, Iran
4Young Researcher's Club, Islamic Azad university, Mashhad branch, Iran

Received 27 February 2011; Accepted 13 May 2011

Academic Editor: Aziz Ghahary

Copyright © 2011 Mohamad Javad Yazdanpanah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Y. Oumeish, “Cutaneous leishmaniasis: a historical perspective,” Clinics in Dermatology, vol. 17, no. 3, pp. 249–254, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. R. D. Pearson, A. De Queiroz Sousu, and S. M. B. Jeronimo, “Leishmania species: visceral (kala-azar), cutaneous and mucosal leishmaniasis,” in Principles and Practice of Infectious Diseases, G. L. Mnadell, J. E. Bennett, and R. Dolin, Eds., pp. 2831–2833, Churchill Livingstone, Philadelphia, Pa, USA, 5 edition, 2000. View at Google Scholar
  3. A. D. M. Bryceson and R. J. Hay, “Parasitic worms and protozoa,” in Rook Textbook of Dermatology, R. H. Champion, J. L. Burton, D. A. Burns, and S. M. Breathnach, Eds., pp. 1411–1412, Blackwell Science, London, UK, 6 edition, 1998. View at Google Scholar
  4. M. Valizadeh, A. H. Dalimi Asl, and A. Fata, “A study on leishmania species causing cutaneous leishmaniasis in mashhad using specific monoclonal antibodies,” Modarres Journal of Medical Sciences, vol. 7, no. 2, pp. 107–113, 2005. View at Google Scholar
  5. P. Desjeux, “Human leishmaniases: epidemiology and public health aspects,” World Health Statistics Quarterly, vol. 45, no. 2-3, pp. 267–275, 1992. View at Google Scholar · View at Scopus
  6. N. I. Neouimine, “Leishmaniasis in the Eastern Mediterranean Region,” Eastern Mediterranean Health Journal, vol. 2, no. 1, pp. 94–101, 1996. View at Google Scholar · View at Scopus
  7. R. A. Najim, K. E. Sharquie, and I. B. Farjou, “Zinc sulphate in the treatment of cutaneous leishmaniasis: an in vitro and animal study,” Memorias do Instituto Oswaldo Cruz, vol. 93, no. 6, pp. 831–837, 1998. View at Google Scholar · View at Scopus
  8. R. A. Najim, K. E. Sharquie, and S. A. Al-Zubaidy, “Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites,” Annals of Tropical Medicine and Parasitology, vol. 100, no. 1, pp. 33–38, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Minodier and P. Parola, “Cutaneous leishmaniasis treatment,” Travel Medicine and Infectious Disease, vol. 5, no. 3, pp. 150–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. K. E. Sharquie, R. A. Najim, and I. B. Farjou, “A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis,” Clinical and Experimental Dermatology, vol. 22, no. 4, pp. 169–173, 1997. View at Google Scholar · View at Scopus
  11. F. Iraji, A. Vali, A. Asilian, M. A. Shahtalebi, and A. Z. Momeni, “Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis,” Dermatology, vol. 209, no. 1, pp. 46–49, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. K. E. Sharquie, R. A. Najim, I. B. Farjou, and D. J. Al-Timimi, “Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis,” Clinical and Experimental Dermatology, vol. 26, no. 1, pp. 21–26, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. M. Al-Mulla Hummadi, N. M. Al-Bashir, and R. A. Najim, “The mechanism behind the antileishmanial effect of zinc sulphate. II. Effects on the enzymes of the parasites,” Annals of Tropical Medicine and Parasitology, vol. 99, no. 2, pp. 131–139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. J. Yazdanpanah, S. K. Mostoufi, and M. Soleymani, “Oral zinc sulfate in the treatment of acute cutaneous leishmaniasis,” Iranian Red Crescent Medical Journal, vol. 9, no. 4, pp. 205–208, 2007. View at Google Scholar
  15. P. Layegh, M. J. Yazdanpanah, S. M. Dadkhah, and E. Mohammadi Vosough, “Comparative study of oral azithromycin and systemic meglumine antimoniate (glucantime) in the treatment of cutaneous leishmaniasis,” Iranian Journal of Dermatology, vol. 9, no. 38, pp. 303–307, 2007. View at Google Scholar
  16. S. Famili, F. Pezeshkpour, and V. Sepehr, “Comparison of efficacy of oral fluconazole with intramuscular glucantime in patients with acute cutaneous leishmaniasis,” Iranian Journal of Dermatology, vol. 8, no. 2, pp. 97–100, 2005. View at Google Scholar
  17. F. Berenji, M. Yaghoobi, A. Akhavan, A. Hanafi, and A. Fata, “A study on vectors of cutaneous Leishmaniasis in northern part of Mashhad, Iran,” Iranian Journal of Medical Sciences, vol. 9, no. 1, pp. 1–6, 2006. View at Google Scholar
  18. I. Arevalo, B. Ward, R. Miller et al., “Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator,” Clinical Infectious Diseases, vol. 33, no. 11, pp. 1847–1851, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Jen, K. N. Shah, and A. C. Yan, “Skin in nutritional, metabolic and heritable disease,” in Dermatology in General Medicine, K. Wolff, L. A. Goldsmith, and S. I. Katz, Eds., p. 1215, McGraw–Hill, New York, NY, USA, 7th edition, 2007. View at Google Scholar